Moxifloxacin-containing triple therapy after non-bismuth quadruple therapy failure for Helicobacter pylori infection

AIM: To assess the efficacy of moxifloxacin-containing triple therapy after non-bismuth quadruple therapy failure for Helicobacter pylori (H. pylori) eradication. METHODS: Between January 2010 and December 2012, we screened individuals who were prescribed non-bismuth quadruple therapy for H. pylori...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:World J Gastroenterol
Egile Nagusiak: Lim, Ji Hyun, Lee, Dong Ho, Lee, Seong Tae, Kim, Nayoung, Park, Young Soo, Shin, Cheol Min, Song, In Sung
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Baishideng Publishing Group Inc 2015
Gaiak:
Retrospective Study
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4674731/
https://ncbi.nlm.nih.gov/pubmed/26673999
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v21.i46.13124
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak